CL
Coloplast A/S
CLPBF · OTC
$62.81 +0.00% (+$0.00)
1M +0.82%
Market Cap 85.6B kr
P/E Ratio 31.06x
Div. Yield 5.70%
ROE 19.65%
Bulios Fair Price
$36.91
41.2% downside
Current Price
$62.81
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CLPBF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
63 /100
Fair EV/EBITDA 9.22x
P/S 3.01x
P/B 6.42x
Growth
45 /100
Stable Rev. growth 7.21%
FCF growth 10.37%
Book val. growth 24.73%
Profitability
93 /100
Strong Net margin 9.70%
Op. margin 26.26%
FCF margin 22.03%
Quality
69 /100
Excellent ROE 19.65%
ROA 5.89%
Asset turnover 0.61x
Debt
60 /100
Moderate Current ratio 1.56x
Int. coverage 10.77x
Net debt/EBITDA 1.95x
Stability
96 /100
Stable Rev. volatility 3.86%
EPS volatility 16.81%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLPBF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Gavin Wood
Employees
16,907
Headquarters
Humlebæk
Upcoming events
03 NOV
Earnings
Upcoming earnings report